This product is Human Serum, not Albumin Human serum. The purity is not measured for the product. The specification of Total Albumin is 4.0 - 9.0 g/dl.
おすすめの製品
由来生物
human
品質水準
無菌性
sterile-filtered
組成
Hemoglobin, ≤25 mg/dL
由来
USA origin
テクニック
cell culture | mammalian: suitable
cell culture | stem cell: suitable
不純物
≤10 EU/mL Endotoxin
輸送温度
dry ice
保管温度
−20°C
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
アプリケーション
ヒトAB血清は、次の目的で組織工学、移植、細胞治療用途に使用します：脂肪組織由来の間葉系幹細胞（MSC）、またはヒト骨髄由来の間葉系間質細胞の増殖。角膜縁上皮幹細胞移植片の継代、移植の標準化。造血幹細胞増殖培地における末梢血由来NK細胞のex vivo増殖。移植前ヒト膵島培養技術の向上。
包装
本品の包装に使用したボトルが不足しているため、バッチごとに包装が異なる場合があります。ボトルキャップの周囲のシュリンクラップの有無によって、製品の完全性/滅菌性が影響されることはありません。
警告
ドナーはそれぞれELISA試験によりB型およびC型肝炎とヒト免疫不全ウイルス(HIV)の抗体に非反応性であることが確認されていますが、念のため、ヒト由来の製品は感染性についてご考慮の上、相応にお取り扱いください。
アナリシスノート
エンドトキシン試験済み
その他情報
本ヒト血清製品が濁ることは珍しいことではありません。本製品はプール血清であり、濁りは血清中に脂質が存在していることを示しています。透明で脂質を含まないヒト血清製品はご用意できません。
免責事項
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
保管分類コード
10 - Combustible liquids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
H5667-20ML-LBL:
H5667-100ML-LBL:
H5667-20ML:
H5667-20ML-PW:
H5667-VAR:
H5667-100ML-PW:
H5667-BULK:
H5667-100ML:
最新バージョンのいずれかを選択してください：
試験成績書（COA）
Lot/Batch Number
この製品を見ている人はこちらもチェック
Tsvetana Petrova et al.
Scientific reports, 10(1), 3479-3479 (2020-02-28)
Type 2 Innate lymphoid cells (ILC2s) are implicated in helminth infections and asthma where they play a role in the production of Th2-type cytokines. ILC2s express the IL-33 receptor and are a major cell type thought to mediate the effects
Julie Kerr-Conte et al.
Transplantation, 89(9), 1154-1160 (2010-01-26)
BACKGROUND.: The original Edmonton protocol used fresh islets, but for obvious logistic advantages most transplant centers have implemented pretransplant culture in human albumin. The aim of this study was to improve current pretransplant human islet culture techniques. METHODS.: Clinical-grade purified
Torkild Visnes et al.
Nucleic acids research, 48(21), 12234-12251 (2020-11-20)
Altered oncogene expression in cancer cells causes loss of redox homeostasis resulting in oxidative DNA damage, e.g. 8-oxoguanine (8-oxoG), repaired by base excision repair (BER). PARP1 coordinates BER and relies on the upstream 8-oxoguanine-DNA glycosylase (OGG1) to recognise and excise
A Poloni et al.
Cytotherapy, 11(2), 153-162 (2009-03-21)
Mesenchymal stromal cells (MSC) are promising candidates for cell therapy and tissue engineering and may be used to treat acute graft-versus-host disease (GvHD). However, major obstacles for their clinical use are the required cell dose and the biosafety and potential
Sangeeta Sule et al.
PloS one, 6(3), e17495-e17495 (2011-03-23)
Monocytes are a key component of the innate immune system involved in the regulation of the adaptive immune response. Previous studies have focused on apoptotic cell clearance abnormalities in systemic lupus erythematosus (SLE) monocytes. However, whether SLE monocytes might express
資料
Find answers to frequently asked questions (FAQs) about FBS and other serum products, and links to related products.
FBSおよびその他の血清製品に関するよくあるお問い合わせ（FAQ）への回答および関連製品のリンクはこちら。
-
What is the percentage of Albumin Human serum in the solution and also provide with the purity of the solution?
1 回答-
役に立ちましたか？
-
-
How many donors are used in each batch?
1 回答-
The average batch of these products is derived from a pool of 180 donors, which may vary from lot to lot.
役に立ちましたか？
-
-
What is the difference between human serum from AB plasma and human serum from AB clotted whole blood?
1 回答-
Product H6914 is prepared from whole blood that is allowed to clot, centrifuged and the serum removed. There is no additional processing required.Product H4522 is prepared from anticoagulated (sodium citrate) whole blood. This is centrifuged to pellet the cells (RBC, WBC, some platelets) and the plasma is removed. This plasma is then treated with calcium to activate the clotting cascade. The preparation is centrifuged again and the supernatant is removed. This product can also be called plasma derived serum.Product H6914 will contain more growth factors since it is allowed to spontaneously clot and there will be the release of growth factors from many of the cells (WBC, platelets) present. The cells are removed before the plasma is clotted for Product H4522, so this plasma will have fewer growth factors present (more similar to what is circulating). Unless testing for growth factors, most researchers are looking for Product H6914.We offer both products heat inactivated.Product H5667 Human Serum Heat Inactivated, from male AB clotted whole bloodProduct H3667 Human Serum Heat Inactivated, from human male AB plasma
役に立ちましたか？
-
-
What is the Department of Transportation shipping information for this product?
1 回答-
Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
役に立ちましたか？
-
アクティブなフィルタ
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）
